context stringlengths 21 33.9k | category stringclasses 2
values | entity stringlengths 1 12 | entity_type stringclasses 5
values | query stringlengths 97 3.31k | answer stringlengths 12 169 |
|---|---|---|---|---|---|
The Company paid dividends on the shares held by the ESOP of $ 17 in 2023, $ 19 in 2022 and $ 20 in 2021. The Company did no t make any contributions to the ESOP in 2023, 2022 or 2021. | text | 19 | monetaryItemType | text: <entity> 19 </entity> <entity type> monetaryItemType </entity type> <context> The Company paid dividends on the shares held by the ESOP of $ 17 in 2023, $ 19 in 2022 and $ 20 in 2021. The Company did no t make any contributions to the ESOP in 2023, 2022 or 2021. </context> | us-gaap:EmployeeStockOwnershipPlanESOPDividendsPaidToESOP |
The Company paid dividends on the shares held by the ESOP of $ 17 in 2023, $ 19 in 2022 and $ 20 in 2021. The Company did no t make any contributions to the ESOP in 2023, 2022 or 2021. | text | 20 | monetaryItemType | text: <entity> 20 </entity> <entity type> monetaryItemType </entity type> <context> The Company paid dividends on the shares held by the ESOP of $ 17 in 2023, $ 19 in 2022 and $ 20 in 2021. The Company did no t make any contributions to the ESOP in 2023, 2022 or 2021. </context> | us-gaap:EmployeeStockOwnershipPlanESOPDividendsPaidToESOP |
In the first quarter of 2023, the Company recorded a charge of $ 267 as a result of a decision of the United States Court of Appeals for the Second Circuit (the “Second Circuit”) affirming a grant of summary judgment to the plaintiffs in a lawsuit under the Employee Retirement Income Security Act seeking the recalculat... | text | 267 | monetaryItemType | text: <entity> 267 </entity> <entity type> monetaryItemType </entity type> <context> In the first quarter of 2023, the Company recorded a charge of $ 267 as a result of a decision of the United States Court of Appeals for the Second Circuit (the “Second Circuit”) affirming a grant of summary judgment to the plaintiffs ... | us-gaap:LitigationSettlementExpense |
During the third quarter of 2022, the Company amended its domestic postretirement plan to limit eligibility for certain existing employees, eliminate eligibility for other existing employees and change the way coverage and subsidies are delivered for certain current and future retirees. As required, the Company remeasu... | text | 398 | monetaryItemType | text: <entity> 398 </entity> <entity type> monetaryItemType </entity type> <context> During the third quarter of 2022, the Company amended its domestic postretirement plan to limit eligibility for certain existing employees, eliminate eligibility for other existing employees and change the way coverage and subsidies ar... | us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses |
The medical cost trend rate of increase assumed in measuring the expected cost of benefits is projected to decrease from 6.00 % in 2024 to 4.88 % by 2028 , remaining at 4.50 % for the years thereafter. | text | 6.00 | percentItemType | text: <entity> 6.00 </entity> <entity type> percentItemType </entity type> <context> The medical cost trend rate of increase assumed in measuring the expected cost of benefits is projected to decrease from 6.00 % in 2024 to 4.88 % by 2028 , remaining at 4.50 % for the years thereafter. </context> | us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear |
The medical cost trend rate of increase assumed in measuring the expected cost of benefits is projected to decrease from 6.00 % in 2024 to 4.88 % by 2028 , remaining at 4.50 % for the years thereafter. | text | 4.50 | percentItemType | text: <entity> 4.50 </entity> <entity type> percentItemType </entity type> <context> The medical cost trend rate of increase assumed in measuring the expected cost of benefits is projected to decrease from 6.00 % in 2024 to 4.88 % by 2028 , remaining at 4.50 % for the years thereafter. </context> | us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1 |
Other postretirement charges for the twelve months ended December 31, 2023 included pension and other charges of $ 5 incurred pursuant to the 2022 Global Productivity Initiative. The Company made no voluntary contributions in 2023, 2022, and 2021. | text | 5 | monetaryItemType | text: <entity> 5 </entity> <entity type> monetaryItemType </entity type> <context> Other postretirement charges for the twelve months ended December 31, 2023 included pension and other charges of $ 5 incurred pursuant to the 2022 Global Productivity Initiative. The Company made no voluntary contributions in 2023, 2022,... | us-gaap:DefinedBenefitPlanOtherCosts |
Net tax benefit of $ 19 and net tax expense of $ 164 and $ 146 were recorded directly through equity in 2023, 2022 and 2021 respectively. The net tax expense or benefit in each year predominantly includes current and future tax impacts related to benefit plans and the impact of currency translation adjustments. | text | 19 | monetaryItemType | text: <entity> 19 </entity> <entity type> monetaryItemType </entity type> <context> Net tax benefit of $ 19 and net tax expense of $ 164 and $ 146 were recorded directly through equity in 2023, 2022 and 2021 respectively. The net tax expense or benefit in each year predominantly includes current and future tax impacts ... | us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity |
Net tax benefit of $ 19 and net tax expense of $ 164 and $ 146 were recorded directly through equity in 2023, 2022 and 2021 respectively. The net tax expense or benefit in each year predominantly includes current and future tax impacts related to benefit plans and the impact of currency translation adjustments. | text | 164 | monetaryItemType | text: <entity> 164 </entity> <entity type> monetaryItemType </entity type> <context> Net tax benefit of $ 19 and net tax expense of $ 164 and $ 146 were recorded directly through equity in 2023, 2022 and 2021 respectively. The net tax expense or benefit in each year predominantly includes current and future tax impacts... | us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity |
Net tax benefit of $ 19 and net tax expense of $ 164 and $ 146 were recorded directly through equity in 2023, 2022 and 2021 respectively. The net tax expense or benefit in each year predominantly includes current and future tax impacts related to benefit plans and the impact of currency translation adjustments. | text | 146 | monetaryItemType | text: <entity> 146 </entity> <entity type> monetaryItemType </entity type> <context> Net tax benefit of $ 19 and net tax expense of $ 164 and $ 146 were recorded directly through equity in 2023, 2022 and 2021 respectively. The net tax expense or benefit in each year predominantly includes current and future tax impacts... | us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity |
If all of the unrecognized tax benefits for 2023 above were recognized, approximately $ 304 would impact the effective tax rate. It is reasonably possible that the amount of unrecognized benefits with respect to our uncertain tax positions could change in the next twelve months and such change may or may not be materia... | text | 304 | monetaryItemType | text: <entity> 304 </entity> <entity type> monetaryItemType </entity type> <context> If all of the unrecognized tax benefits for 2023 above were recognized, approximately $ 304 would impact the effective tax rate. It is reasonably possible that the amount of unrecognized benefits with respect to our uncertain tax posit... | us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate |
The Company recognized expense of approximately $ 10 , $ 8 and $ 10 for interest and penalties related to the above unrecognized tax benefits within income tax expense in 2023, 2022 and 2021, respectively. The Company had accrued interest and penalties of approximately $ 45 , $ 40 and $ 35 as of December 31, 2023, 2022... | text | 10 | monetaryItemType | text: <entity> 10 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized expense of approximately $ 10 , $ 8 and $ 10 for interest and penalties related to the above unrecognized tax benefits within income tax expense in 2023, 2022 and 2021, respectively. The Company had accrued intere... | us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense |
The Company recognized expense of approximately $ 10 , $ 8 and $ 10 for interest and penalties related to the above unrecognized tax benefits within income tax expense in 2023, 2022 and 2021, respectively. The Company had accrued interest and penalties of approximately $ 45 , $ 40 and $ 35 as of December 31, 2023, 2022... | text | 8 | monetaryItemType | text: <entity> 8 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized expense of approximately $ 10 , $ 8 and $ 10 for interest and penalties related to the above unrecognized tax benefits within income tax expense in 2023, 2022 and 2021, respectively. The Company had accrued interes... | us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense |
The Company recognized expense of approximately $ 10 , $ 8 and $ 10 for interest and penalties related to the above unrecognized tax benefits within income tax expense in 2023, 2022 and 2021, respectively. The Company had accrued interest and penalties of approximately $ 45 , $ 40 and $ 35 as of December 31, 2023, 2022... | text | 45 | monetaryItemType | text: <entity> 45 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized expense of approximately $ 10 , $ 8 and $ 10 for interest and penalties related to the above unrecognized tax benefits within income tax expense in 2023, 2022 and 2021, respectively. The Company had accrued intere... | us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued |
The Company recognized expense of approximately $ 10 , $ 8 and $ 10 for interest and penalties related to the above unrecognized tax benefits within income tax expense in 2023, 2022 and 2021, respectively. The Company had accrued interest and penalties of approximately $ 45 , $ 40 and $ 35 as of December 31, 2023, 2022... | text | 40 | monetaryItemType | text: <entity> 40 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized expense of approximately $ 10 , $ 8 and $ 10 for interest and penalties related to the above unrecognized tax benefits within income tax expense in 2023, 2022 and 2021, respectively. The Company had accrued intere... | us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued |
The Company recognized expense of approximately $ 10 , $ 8 and $ 10 for interest and penalties related to the above unrecognized tax benefits within income tax expense in 2023, 2022 and 2021, respectively. The Company had accrued interest and penalties of approximately $ 45 , $ 40 and $ 35 as of December 31, 2023, 2022... | text | 35 | monetaryItemType | text: <entity> 35 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized expense of approximately $ 10 , $ 8 and $ 10 for interest and penalties related to the above unrecognized tax benefits within income tax expense in 2023, 2022 and 2021, respectively. The Company had accrued intere... | us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued |
In the second quarter of 2023, the Company reassessed with its legal and tax advisers certain tax deductions taken in prior years by one of its subsidiaries and concluded that it is more likely than not that the deductions would not be sustained by the courts in that jurisdiction. The value of the tax deductions was no... | text | 22 | monetaryItemType | text: <entity> 22 </entity> <entity type> monetaryItemType </entity type> <context> In the second quarter of 2023, the Company reassessed with its legal and tax advisers certain tax deductions taken in prior years by one of its subsidiaries and concluded that it is more likely than not that the deductions would not be ... | us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions |
The Company has ongoing federal, state and international income tax audits in various jurisdictions and evaluates uncertain tax positions that may be challenged by local tax authorities and not fully sustained. All U.S. federal income tax returns through December 31, 2013 have been audited by the IRS and there are limi... | text | 145 | monetaryItemType | text: <entity> 145 </entity> <entity type> monetaryItemType </entity type> <context> The Company has ongoing federal, state and international income tax audits in various jurisdictions and evaluates uncertain tax positions that may be challenged by local tax authorities and not fully sustained. All U.S. federal income ... | us-gaap:IncomeTaxExaminationEstimateOfPossibleLoss |
For the years ended December 31, 2023, 2022 and 2021, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 13,719,286 , 5,236,371 and 2,495,393 , respectively. For the years ended December 31, 2023, 2022 and 2021, the average number of restricted s... | text | 13719286 | sharesItemType | text: <entity> 13719286 </entity> <entity type> sharesItemType </entity type> <context> For the years ended December 31, 2023, 2022 and 2021, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 13,719,286 , 5,236,371 and 2,495,393 , respectively. ... | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
For the years ended December 31, 2023, 2022 and 2021, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 13,719,286 , 5,236,371 and 2,495,393 , respectively. For the years ended December 31, 2023, 2022 and 2021, the average number of restricted s... | text | 5236371 | sharesItemType | text: <entity> 5236371 </entity> <entity type> sharesItemType </entity type> <context> For the years ended December 31, 2023, 2022 and 2021, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 13,719,286 , 5,236,371 and 2,495,393 , respectively. F... | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
For the years ended December 31, 2023, 2022 and 2021, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 13,719,286 , 5,236,371 and 2,495,393 , respectively. For the years ended December 31, 2023, 2022 and 2021, the average number of restricted s... | text | 2495393 | sharesItemType | text: <entity> 2495393 </entity> <entity type> sharesItemType </entity type> <context> For the years ended December 31, 2023, 2022 and 2021, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 13,719,286 , 5,236,371 and 2,495,393 , respectively. F... | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
For the years ended December 31, 2023, 2022 and 2021, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 13,719,286 , 5,236,371 and 2,495,393 , respectively. For the years ended December 31, 2023, 2022 and 2021, the average number of restricted s... | text | 1183 | sharesItemType | text: <entity> 1183 </entity> <entity type> sharesItemType </entity type> <context> For the years ended December 31, 2023, 2022 and 2021, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 13,719,286 , 5,236,371 and 2,495,393 , respectively. For ... | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
For the years ended December 31, 2023, 2022 and 2021, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 13,719,286 , 5,236,371 and 2,495,393 , respectively. For the years ended December 31, 2023, 2022 and 2021, the average number of restricted s... | text | 155118 | sharesItemType | text: <entity> 155118 </entity> <entity type> sharesItemType </entity type> <context> For the years ended December 31, 2023, 2022 and 2021, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 13,719,286 , 5,236,371 and 2,495,393 , respectively. Fo... | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
For the years ended December 31, 2023, 2022 and 2021, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 13,719,286 , 5,236,371 and 2,495,393 , respectively. For the years ended December 31, 2023, 2022 and 2021, the average number of restricted s... | text | 126378 | sharesItemType | text: <entity> 126378 </entity> <entity type> sharesItemType </entity type> <context> For the years ended December 31, 2023, 2022 and 2021, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 13,719,286 , 5,236,371 and 2,495,393 , respectively. Fo... | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
As of December 31, 2023, the Company has various contractual commitments for future multi-year purchases of raw, packaging and other materials totaling approximately $ 757 . | text | 757 | monetaryItemType | text: <entity> 757 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, the Company has various contractual commitments for future multi-year purchases of raw, packaging and other materials totaling approximately $ 757 . </context> | us-gaap:LongTermPurchaseCommitmentAmount |
As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regula... | text | 200 | integerItemType | text: <entity> 200 </entity> <entity type> integerItemType </entity type> <context> As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liab... | us-gaap:NumberOfCountriesInWhichEntityOperates |
The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below for which the amount of an... | text | 0 | monetaryItemType | text: <entity> 0 </entity> <entity type> monetaryItemType </entity type> <context> The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to det... | us-gaap:LossContingencyEstimateOfPossibleLoss |
The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below for which the amount of an... | text | 300 | monetaryItemType | text: <entity> 300 </entity> <entity type> monetaryItemType </entity type> <context> The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to d... | us-gaap:LossContingencyEstimateOfPossibleLoss |
The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos and/or caused mesothelioma and other cancers. Many of these actions involve a number of co-defendants from a variety of different industries, including sup... | text | 278 | integerItemType | text: <entity> 278 </entity> <entity type> integerItemType </entity type> <context> The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos and/or caused mesothelioma and other cancers. Many of these actions inv... | us-gaap:LossContingencyPendingClaimsNumber |
The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos and/or caused mesothelioma and other cancers. Many of these actions involve a number of co-defendants from a variety of different industries, including sup... | text | 227 | integerItemType | text: <entity> 227 </entity> <entity type> integerItemType </entity type> <context> The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos and/or caused mesothelioma and other cancers. Many of these actions inv... | us-gaap:LossContingencyPendingClaimsNumber |
The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos and/or caused mesothelioma and other cancers. Many of these actions involve a number of co-defendants from a variety of different industries, including sup... | text | 169 | integerItemType | text: <entity> 169 </entity> <entity type> integerItemType </entity type> <context> The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos and/or caused mesothelioma and other cancers. Many of these actions inv... | us-gaap:LossContingencyNewClaimsFiledNumber |
The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos and/or caused mesothelioma and other cancers. Many of these actions involve a number of co-defendants from a variety of different industries, including sup... | text | 118 | integerItemType | text: <entity> 118 </entity> <entity type> integerItemType </entity type> <context> The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos and/or caused mesothelioma and other cancers. Many of these actions inv... | us-gaap:LossContingencyClaimsSettledAndDismissedNumber |
In light of the Second Circuit decision, the Company recorded a charge to earnings of $ 267 in the quarter ended March 31, 2023, which is comprised of the recalculation of benefits and interest. Possible additional charges associated with this matter are expected to be immaterial and, where estimable, are reflected in ... | text | 267 | monetaryItemType | text: <entity> 267 </entity> <entity type> monetaryItemType </entity type> <context> In light of the Second Circuit decision, the Company recorded a charge to earnings of $ 267 in the quarter ended March 31, 2023, which is comprised of the recalculation of benefits and interest. Possible additional charges associated w... | us-gaap:LitigationSettlementExpense |
The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. | text | two | integerItemType | text: <entity> two </entity> <entity type> integerItemType </entity type> <context> The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. </context> | us-gaap:NumberOfOperatingSegments |
Approximately two-thirds of the Company’s Net sales are generated from markets outside the U.S., with approximately 45 % of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). Oral, Personal and Home Care sales to Walmart, Inc... | text | 11 | percentItemType | text: <entity> 11 </entity> <entity type> percentItemType </entity type> <context> Approximately two-thirds of the Company’s Net sales are generated from markets outside the U.S., with approximately 45 % of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Afr... | us-gaap:ConcentrationRiskPercentage1 |
Approximately two-thirds of the Company’s Net sales are generated from markets outside the U.S., with approximately 45 % of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). Oral, Personal and Home Care sales to Walmart, Inc... | text | 12 | percentItemType | text: <entity> 12 </entity> <entity type> percentItemType </entity type> <context> Approximately two-thirds of the Company’s Net sales are generated from markets outside the U.S., with approximately 45 % of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Afr... | us-gaap:ConcentrationRiskPercentage1 |
In 2023, Corporate Operating profit included charges resulting from the 2022 Global Productivity Initiative of $ 27 and product recall costs of $ 25 . In 2022, Corporate Operating profit included goodwill and intangible assets impairment charges of $ 721 , charges resulting from the 2022 Global Productivity Initiative ... | text | 27 | monetaryItemType | text: <entity> 27 </entity> <entity type> monetaryItemType </entity type> <context> In 2023, Corporate Operating profit included charges resulting from the 2022 Global Productivity Initiative of $ 27 and product recall costs of $ 25 . In 2022, Corporate Operating profit included goodwill and intangible assets impairmen... | us-gaap:RestructuringCosts |
In 2023, Corporate Operating profit included charges resulting from the 2022 Global Productivity Initiative of $ 27 and product recall costs of $ 25 . In 2022, Corporate Operating profit included goodwill and intangible assets impairment charges of $ 721 , charges resulting from the 2022 Global Productivity Initiative ... | text | 25 | monetaryItemType | text: <entity> 25 </entity> <entity type> monetaryItemType </entity type> <context> In 2023, Corporate Operating profit included charges resulting from the 2022 Global Productivity Initiative of $ 27 and product recall costs of $ 25 . In 2022, Corporate Operating profit included goodwill and intangible assets impairmen... | us-gaap:RestructuringCosts |
In 2023, Corporate Operating profit included charges resulting from the 2022 Global Productivity Initiative of $ 27 and product recall costs of $ 25 . In 2022, Corporate Operating profit included goodwill and intangible assets impairment charges of $ 721 , charges resulting from the 2022 Global Productivity Initiative ... | text | 95 | monetaryItemType | text: <entity> 95 </entity> <entity type> monetaryItemType </entity type> <context> In 2023, Corporate Operating profit included charges resulting from the 2022 Global Productivity Initiative of $ 27 and product recall costs of $ 25 . In 2022, Corporate Operating profit included goodwill and intangible assets impairmen... | us-gaap:RestructuringAndRelatedCostIncurredCost |
In 2023, Corporate Operating profit included charges resulting from the 2022 Global Productivity Initiative of $ 27 and product recall costs of $ 25 . In 2022, Corporate Operating profit included goodwill and intangible assets impairment charges of $ 721 , charges resulting from the 2022 Global Productivity Initiative ... | text | 47 | monetaryItemType | text: <entity> 47 </entity> <entity type> monetaryItemType </entity type> <context> In 2023, Corporate Operating profit included charges resulting from the 2022 Global Productivity Initiative of $ 27 and product recall costs of $ 25 . In 2022, Corporate Operating profit included goodwill and intangible assets impairmen... | us-gaap:GainLossOnSaleOfProperties |
In 2023, Corporate Operating profit included charges resulting from the 2022 Global Productivity Initiative of $ 27 and product recall costs of $ 25 . In 2022, Corporate Operating profit included goodwill and intangible assets impairment charges of $ 721 , charges resulting from the 2022 Global Productivity Initiative ... | text | 19 | monetaryItemType | text: <entity> 19 </entity> <entity type> monetaryItemType </entity type> <context> In 2023, Corporate Operating profit included charges resulting from the 2022 Global Productivity Initiative of $ 27 and product recall costs of $ 25 . In 2022, Corporate Operating profit included goodwill and intangible assets impairmen... | us-gaap:BusinessCombinationAcquisitionRelatedCosts |
Net sales in the U.S. for Oral, Personal and Home Care were $ 3,625 , $ 3,511 and $ 3,391 in 2023, 2022 and 2021, respectively. | text | 3625 | monetaryItemType | text: <entity> 3625 </entity> <entity type> monetaryItemType </entity type> <context> Net sales in the U.S. for Oral, Personal and Home Care were $ 3,625 , $ 3,511 and $ 3,391 in 2023, 2022 and 2021, respectively. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
Net sales in the U.S. for Oral, Personal and Home Care were $ 3,625 , $ 3,511 and $ 3,391 in 2023, 2022 and 2021, respectively. | text | 3511 | monetaryItemType | text: <entity> 3511 </entity> <entity type> monetaryItemType </entity type> <context> Net sales in the U.S. for Oral, Personal and Home Care were $ 3,625 , $ 3,511 and $ 3,391 in 2023, 2022 and 2021, respectively. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
Net sales in the U.S. for Oral, Personal and Home Care were $ 3,625 , $ 3,511 and $ 3,391 in 2023, 2022 and 2021, respectively. | text | 3391 | monetaryItemType | text: <entity> 3391 </entity> <entity type> monetaryItemType </entity type> <context> Net sales in the U.S. for Oral, Personal and Home Care were $ 3,625 , $ 3,511 and $ 3,391 in 2023, 2022 and 2021, respectively. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
Net sales in the U.S. for Pet Nutrition were $ 2,918 , $ 2,432 and $ 2,018 in 2023, 2022 and 2021, respectively. | text | 2918 | monetaryItemType | text: <entity> 2918 </entity> <entity type> monetaryItemType </entity type> <context> Net sales in the U.S. for Pet Nutrition were $ 2,918 , $ 2,432 and $ 2,018 in 2023, 2022 and 2021, respectively. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
Net sales in the U.S. for Pet Nutrition were $ 2,918 , $ 2,432 and $ 2,018 in 2023, 2022 and 2021, respectively. | text | 2432 | monetaryItemType | text: <entity> 2432 </entity> <entity type> monetaryItemType </entity type> <context> Net sales in the U.S. for Pet Nutrition were $ 2,918 , $ 2,432 and $ 2,018 in 2023, 2022 and 2021, respectively. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
Net sales in the U.S. for Pet Nutrition were $ 2,918 , $ 2,432 and $ 2,018 in 2023, 2022 and 2021, respectively. | text | 2018 | monetaryItemType | text: <entity> 2018 </entity> <entity type> monetaryItemType </entity type> <context> Net sales in the U.S. for Pet Nutrition were $ 2,918 , $ 2,432 and $ 2,018 in 2023, 2022 and 2021, respectively. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
Payments against amounts included in the measurement of lease liabilities: $ 171 and $ 169 , respectively | text | 171 | monetaryItemType | text: <entity> 171 </entity> <entity type> monetaryItemType </entity type> <context> Payments against amounts included in the measurement of lease liabilities: $ 171 and $ 169 , respectively </context> | us-gaap:OperatingLeasePayments |
Payments against amounts included in the measurement of lease liabilities: $ 171 and $ 169 , respectively | text | 169 | monetaryItemType | text: <entity> 169 </entity> <entity type> monetaryItemType </entity type> <context> Payments against amounts included in the measurement of lease liabilities: $ 171 and $ 169 , respectively </context> | us-gaap:OperatingLeasePayments |
Lease assets obtained in exchange for lease liabilities: $ 139 and $ 85 , respectively. | text | 139 | monetaryItemType | text: <entity> 139 </entity> <entity type> monetaryItemType </entity type> <context> Lease assets obtained in exchange for lease liabilities: $ 139 and $ 85 , respectively. </context> | us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability |
Lease assets obtained in exchange for lease liabilities: $ 139 and $ 85 , respectively. | text | 85 | monetaryItemType | text: <entity> 85 </entity> <entity type> monetaryItemType </entity type> <context> Lease assets obtained in exchange for lease liabilities: $ 139 and $ 85 , respectively. </context> | us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability |
As of December 31, 2023 and 2022, the weighted-average remaining lease term for operating leases was 8 and 7 years, respectively, and the weighted-average discount rate for operating leases was 4.5 % and 3.9 %, respectively. | text | 4.5 | percentItemType | text: <entity> 4.5 </entity> <entity type> percentItemType </entity type> <context> As of December 31, 2023 and 2022, the weighted-average remaining lease term for operating leases was 8 and 7 years, respectively, and the weighted-average discount rate for operating leases was 4.5 % and 3.9 %, respectively. </context> | us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent |
As of December 31, 2023 and 2022, the weighted-average remaining lease term for operating leases was 8 and 7 years, respectively, and the weighted-average discount rate for operating leases was 4.5 % and 3.9 %, respectively. | text | 3.9 | percentItemType | text: <entity> 3.9 </entity> <entity type> percentItemType </entity type> <context> As of December 31, 2023 and 2022, the weighted-average remaining lease term for operating leases was 8 and 7 years, respectively, and the weighted-average discount rate for operating leases was 4.5 % and 3.9 %, respectively. </context> | us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent |
Inventories valued under LIFO amounted to $ 471 and $ 458 at December 31, 2023 and 2022, respectively. The excess of current cost over LIFO cost at the end of each year was $ 120 and $ 146 , respectively. The liquidations of LIFO inventory quantities had no material effect on income in 2023, 2022 and 2021. Inventory cl... | text | 471 | monetaryItemType | text: <entity> 471 </entity> <entity type> monetaryItemType </entity type> <context> Inventories valued under LIFO amounted to $ 471 and $ 458 at December 31, 2023 and 2022, respectively. The excess of current cost over LIFO cost at the end of each year was $ 120 and $ 146 , respectively. The liquidations of LIFO inven... | us-gaap:LIFOInventoryAmount |
Inventories valued under LIFO amounted to $ 471 and $ 458 at December 31, 2023 and 2022, respectively. The excess of current cost over LIFO cost at the end of each year was $ 120 and $ 146 , respectively. The liquidations of LIFO inventory quantities had no material effect on income in 2023, 2022 and 2021. Inventory cl... | text | 458 | monetaryItemType | text: <entity> 458 </entity> <entity type> monetaryItemType </entity type> <context> Inventories valued under LIFO amounted to $ 471 and $ 458 at December 31, 2023 and 2022, respectively. The excess of current cost over LIFO cost at the end of each year was $ 120 and $ 146 , respectively. The liquidations of LIFO inven... | us-gaap:LIFOInventoryAmount |
Inventories valued under LIFO amounted to $ 471 and $ 458 at December 31, 2023 and 2022, respectively. The excess of current cost over LIFO cost at the end of each year was $ 120 and $ 146 , respectively. The liquidations of LIFO inventory quantities had no material effect on income in 2023, 2022 and 2021. Inventory cl... | text | 120 | monetaryItemType | text: <entity> 120 </entity> <entity type> monetaryItemType </entity type> <context> Inventories valued under LIFO amounted to $ 471 and $ 458 at December 31, 2023 and 2022, respectively. The excess of current cost over LIFO cost at the end of each year was $ 120 and $ 146 , respectively. The liquidations of LIFO inven... | us-gaap:ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue |
Inventories valued under LIFO amounted to $ 471 and $ 458 at December 31, 2023 and 2022, respectively. The excess of current cost over LIFO cost at the end of each year was $ 120 and $ 146 , respectively. The liquidations of LIFO inventory quantities had no material effect on income in 2023, 2022 and 2021. Inventory cl... | text | 146 | monetaryItemType | text: <entity> 146 </entity> <entity type> monetaryItemType </entity type> <context> Inventories valued under LIFO amounted to $ 471 and $ 458 at December 31, 2023 and 2022, respectively. The excess of current cost over LIFO cost at the end of each year was $ 120 and $ 146 , respectively. The liquidations of LIFO inven... | us-gaap:ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue |
Accumulated other comprehensive income (loss) is comprised of cumulative foreign currency translation gains and losses, unrecognized pension and other retiree benefit costs and unrealized gains and losses from derivative instruments designated as cash flow hedges. At December 31, 2023 and 2022, Accumulated other compre... | text | 647 | monetaryItemType | text: <entity> 647 </entity> <entity type> monetaryItemType </entity type> <context> Accumulated other comprehensive income (loss) is comprised of cumulative foreign currency translation gains and losses, unrecognized pension and other retiree benefit costs and unrealized gains and losses from derivative instruments de... | us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax |
Accumulated other comprehensive income (loss) is comprised of cumulative foreign currency translation gains and losses, unrecognized pension and other retiree benefit costs and unrealized gains and losses from derivative instruments designated as cash flow hedges. At December 31, 2023 and 2022, Accumulated other compre... | text | 631 | monetaryItemType | text: <entity> 631 </entity> <entity type> monetaryItemType </entity type> <context> Accumulated other comprehensive income (loss) is comprised of cumulative foreign currency translation gains and losses, unrecognized pension and other retiree benefit costs and unrealized gains and losses from derivative instruments de... | us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax |
Accumulated other comprehensive income (loss) is comprised of cumulative foreign currency translation gains and losses, unrecognized pension and other retiree benefit costs and unrealized gains and losses from derivative instruments designated as cash flow hedges. At December 31, 2023 and 2022, Accumulated other compre... | text | 3351 | monetaryItemType | text: <entity> 3351 </entity> <entity type> monetaryItemType </entity type> <context> Accumulated other comprehensive income (loss) is comprised of cumulative foreign currency translation gains and losses, unrecognized pension and other retiree benefit costs and unrealized gains and losses from derivative instruments d... | us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax |
Accumulated other comprehensive income (loss) is comprised of cumulative foreign currency translation gains and losses, unrecognized pension and other retiree benefit costs and unrealized gains and losses from derivative instruments designated as cash flow hedges. At December 31, 2023 and 2022, Accumulated other compre... | text | 3491 | monetaryItemType | text: <entity> 3491 </entity> <entity type> monetaryItemType </entity type> <context> Accumulated other comprehensive income (loss) is comprised of cumulative foreign currency translation gains and losses, unrecognized pension and other retiree benefit costs and unrealized gains and losses from derivative instruments d... | us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax |
As of the date of the company’s 2023 annual impairment test, the fair value of all reporting units exceeded their carrying values by more than 19 %. Discount rates are one of the more significant assumptions used in the income approach. If the company increased the discount rates used by 100 basis points, the fair valu... | text | 19 | percentItemType | text: <entity> 19 </entity> <entity type> percentItemType </entity type> <context> As of the date of the company’s 2023 annual impairment test, the fair value of all reporting units exceeded their carrying values by more than 19 %. Discount rates are one of the more significant assumptions used in the income approach. ... | us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount |
As of December 31, 2023, the company has $ 2.1 billion of goodwill, of which approximately $ 568.2 million and $ 110.0 million was allocated to the Americas and EMEA reporting units within the global components reportable segment, respectively, $ 783.6 million and $ 391.7 million was allocated to the North America and ... | text | 2.1 | monetaryItemType | text: <entity> 2.1 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, the company has $ 2.1 billion of goodwill, of which approximately $ 568.2 million and $ 110.0 million was allocated to the Americas and EMEA reporting units within the global components reportable segment, resp... | us-gaap:Goodwill |
As of December 31, 2023, the company has $ 2.1 billion of goodwill, of which approximately $ 568.2 million and $ 110.0 million was allocated to the Americas and EMEA reporting units within the global components reportable segment, respectively, $ 783.6 million and $ 391.7 million was allocated to the North America and ... | text | 568.2 | monetaryItemType | text: <entity> 568.2 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, the company has $ 2.1 billion of goodwill, of which approximately $ 568.2 million and $ 110.0 million was allocated to the Americas and EMEA reporting units within the global components reportable segment, re... | us-gaap:Goodwill |
As of December 31, 2023, the company has $ 2.1 billion of goodwill, of which approximately $ 568.2 million and $ 110.0 million was allocated to the Americas and EMEA reporting units within the global components reportable segment, respectively, $ 783.6 million and $ 391.7 million was allocated to the North America and ... | text | 110.0 | monetaryItemType | text: <entity> 110.0 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, the company has $ 2.1 billion of goodwill, of which approximately $ 568.2 million and $ 110.0 million was allocated to the Americas and EMEA reporting units within the global components reportable segment, re... | us-gaap:Goodwill |
As of December 31, 2023, the company has $ 2.1 billion of goodwill, of which approximately $ 568.2 million and $ 110.0 million was allocated to the Americas and EMEA reporting units within the global components reportable segment, respectively, $ 783.6 million and $ 391.7 million was allocated to the North America and ... | text | 783.6 | monetaryItemType | text: <entity> 783.6 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, the company has $ 2.1 billion of goodwill, of which approximately $ 568.2 million and $ 110.0 million was allocated to the Americas and EMEA reporting units within the global components reportable segment, re... | us-gaap:Goodwill |
As of December 31, 2023, the company has $ 2.1 billion of goodwill, of which approximately $ 568.2 million and $ 110.0 million was allocated to the Americas and EMEA reporting units within the global components reportable segment, respectively, $ 783.6 million and $ 391.7 million was allocated to the North America and ... | text | 391.7 | monetaryItemType | text: <entity> 391.7 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, the company has $ 2.1 billion of goodwill, of which approximately $ 568.2 million and $ 110.0 million was allocated to the Americas and EMEA reporting units within the global components reportable segment, re... | us-gaap:Goodwill |
As of December 31, 2023, the company has $ 2.1 billion of goodwill, of which approximately $ 568.2 million and $ 110.0 million was allocated to the Americas and EMEA reporting units within the global components reportable segment, respectively, $ 783.6 million and $ 391.7 million was allocated to the North America and ... | text | 197.0 | monetaryItemType | text: <entity> 197.0 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, the company has $ 2.1 billion of goodwill, of which approximately $ 568.2 million and $ 110.0 million was allocated to the Americas and EMEA reporting units within the global components reportable segment, re... | us-gaap:Goodwill |
Operating segments are defined as components of an enterprise for which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The company’s operations are classified into two reportable segments: ... | text | two | integerItemType | text: <entity> two </entity> <entity type> integerItemType </entity type> <context> Operating segments are defined as components of an enterprise for which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing... | us-gaap:NumberOfReportableSegments |
No single customer accounted for more than 2 % of the company’s 2023 consolidated sales. One supplier accounted for approximately 10 % of the company’s consolidated sales in 2023. The company believes that many of the products it sells are available from other sources at competitive prices. However, certain parts of th... | text | 2 | percentItemType | text: <entity> 2 </entity> <entity type> percentItemType </entity type> <context> No single customer accounted for more than 2 % of the company’s 2023 consolidated sales. One supplier accounted for approximately 10 % of the company’s consolidated sales in 2023. The company believes that many of the products it sells ar... | us-gaap:ConcentrationRiskPercentage1 |
No single customer accounted for more than 2 % of the company’s 2023 consolidated sales. One supplier accounted for approximately 10 % of the company’s consolidated sales in 2023. The company believes that many of the products it sells are available from other sources at competitive prices. However, certain parts of th... | text | 10 | percentItemType | text: <entity> 10 </entity> <entity type> percentItemType </entity type> <context> No single customer accounted for more than 2 % of the company’s 2023 consolidated sales. One supplier accounted for approximately 10 % of the company’s consolidated sales in 2023. The company believes that many of the products it sells a... | us-gaap:ConcentrationRiskPercentage1 |
Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024 through 2028 is estimated to be approximately $ 29.5 million, $ 20.3 million, $ 19.5 ... | text | 31.2 | monetaryItemType | text: <entity> 31.2 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024... | us-gaap:AmortizationOfIntangibleAssets |
Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024 through 2028 is estimated to be approximately $ 29.5 million, $ 20.3 million, $ 19.5 ... | text | 34.7 | monetaryItemType | text: <entity> 34.7 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024... | us-gaap:AmortizationOfIntangibleAssets |
Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024 through 2028 is estimated to be approximately $ 29.5 million, $ 20.3 million, $ 19.5 ... | text | 36.9 | monetaryItemType | text: <entity> 36.9 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024... | us-gaap:AmortizationOfIntangibleAssets |
Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024 through 2028 is estimated to be approximately $ 29.5 million, $ 20.3 million, $ 19.5 ... | text | 29.5 | monetaryItemType | text: <entity> 29.5 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024... | us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths |
Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024 through 2028 is estimated to be approximately $ 29.5 million, $ 20.3 million, $ 19.5 ... | text | 20.3 | monetaryItemType | text: <entity> 20.3 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024... | us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo |
Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024 through 2028 is estimated to be approximately $ 29.5 million, $ 20.3 million, $ 19.5 ... | text | 19.5 | monetaryItemType | text: <entity> 19.5 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024... | us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree |
Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024 through 2028 is estimated to be approximately $ 29.5 million, $ 20.3 million, $ 19.5 ... | text | 18.9 | monetaryItemType | text: <entity> 18.9 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024... | us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour |
Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024 through 2028 is estimated to be approximately $ 29.5 million, $ 20.3 million, $ 19.5 ... | text | 11.2 | monetaryItemType | text: <entity> 11.2 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense related to identifiable intangible assets was $ 31.2 million, $ 34.7 million, and $ 36.9 million for the years ended December 31, 2023, 2022, and 2021, respectively. Amortization expense for each of the years 2024... | us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive |
The company owns a 50 % interest in two joint ventures with Marubun Corporation (collectively “Marubun/Arrow”) and a 50 % interest in one other joint venture. These investments are accounted for using the equity method. | text | 50 | percentItemType | text: <entity> 50 </entity> <entity type> percentItemType </entity type> <context> The company owns a 50 % interest in two joint ventures with Marubun Corporation (collectively “Marubun/Arrow”) and a 50 % interest in one other joint venture. These investments are accounted for using the equity method. </context> | us-gaap:EquityMethodInvestmentOwnershipPercentage |
The company monitors the current credit condition of its customers and other available information about expected credit losses in estimating its allowance for credit losses. During 2023, increases to the allowance for credit losses charged to income were $ 37.4 million higher than the prior year, primarily due to the ... | text | 37.4 | monetaryItemType | text: <entity> 37.4 </entity> <entity type> monetaryItemType </entity type> <context> The company monitors the current credit condition of its customers and other available information about expected credit losses in estimating its allowance for credit losses. During 2023, increases to the allowance for credit losses c... | us-gaap:FinancingReceivableAllowanceForCreditLossesRecovery |
The company has $ 500.0 million in uncommitted lines of credit. In May 2023, the company increased the borrowing capacity on its uncommitted lines from $ 200.0 million to $ 500.0 million. There were no outstanding borrowings under the uncommitted lines of credit at December 31, 2023 and $ 78.0 million in outstanding b... | text | 500.0 | monetaryItemType | text: <entity> 500.0 </entity> <entity type> monetaryItemType </entity type> <context> The company has $ 500.0 million in uncommitted lines of credit. In May 2023, the company increased the borrowing capacity on its uncommitted lines from $ 200.0 million to $ 500.0 million. There were no outstanding borrowings under t... | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
The company has $ 500.0 million in uncommitted lines of credit. In May 2023, the company increased the borrowing capacity on its uncommitted lines from $ 200.0 million to $ 500.0 million. There were no outstanding borrowings under the uncommitted lines of credit at December 31, 2023 and $ 78.0 million in outstanding b... | text | 200.0 | monetaryItemType | text: <entity> 200.0 </entity> <entity type> monetaryItemType </entity type> <context> The company has $ 500.0 million in uncommitted lines of credit. In May 2023, the company increased the borrowing capacity on its uncommitted lines from $ 200.0 million to $ 500.0 million. There were no outstanding borrowings under t... | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
The company has $ 500.0 million in uncommitted lines of credit. In May 2023, the company increased the borrowing capacity on its uncommitted lines from $ 200.0 million to $ 500.0 million. There were no outstanding borrowings under the uncommitted lines of credit at December 31, 2023 and $ 78.0 million in outstanding b... | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> The company has $ 500.0 million in uncommitted lines of credit. In May 2023, the company increased the borrowing capacity on its uncommitted lines from $ 200.0 million to $ 500.0 million. There were no outstanding borrowings under the ... | us-gaap:LinesOfCreditCurrent |
The company has $ 500.0 million in uncommitted lines of credit. In May 2023, the company increased the borrowing capacity on its uncommitted lines from $ 200.0 million to $ 500.0 million. There were no outstanding borrowings under the uncommitted lines of credit at December 31, 2023 and $ 78.0 million in outstanding b... | text | 78.0 | monetaryItemType | text: <entity> 78.0 </entity> <entity type> monetaryItemType </entity type> <context> The company has $ 500.0 million in uncommitted lines of credit. In May 2023, the company increased the borrowing capacity on its uncommitted lines from $ 200.0 million to $ 500.0 million. There were no outstanding borrowings under th... | us-gaap:LinesOfCreditCurrent |
The company has $ 500.0 million in uncommitted lines of credit. In May 2023, the company increased the borrowing capacity on its uncommitted lines from $ 200.0 million to $ 500.0 million. There were no outstanding borrowings under the uncommitted lines of credit at December 31, 2023 and $ 78.0 million in outstanding b... | text | 5.83 | percentItemType | text: <entity> 5.83 </entity> <entity type> percentItemType </entity type> <context> The company has $ 500.0 million in uncommitted lines of credit. In May 2023, the company increased the borrowing capacity on its uncommitted lines from $ 200.0 million to $ 500.0 million. There were no outstanding borrowings under the... | us-gaap:ShortTermDebtWeightedAverageInterestRate |
The company has $ 500.0 million in uncommitted lines of credit. In May 2023, the company increased the borrowing capacity on its uncommitted lines from $ 200.0 million to $ 500.0 million. There were no outstanding borrowings under the uncommitted lines of credit at December 31, 2023 and $ 78.0 million in outstanding b... | text | 5.22 | percentItemType | text: <entity> 5.22 </entity> <entity type> percentItemType </entity type> <context> The company has $ 500.0 million in uncommitted lines of credit. In May 2023, the company increased the borrowing capacity on its uncommitted lines from $ 200.0 million to $ 500.0 million. There were no outstanding borrowings under the... | us-gaap:ShortTermDebtWeightedAverageInterestRate |
The company has a commercial paper program and the maximum aggregate balance of commercial paper outstanding may not exceed the borrowing capacity of $ 1.2 billion. Amounts outstanding under the commercial paper program are backstopped by available commitments under the company’s revolving credit facility. There were $... | text | 1.2 | monetaryItemType | text: <entity> 1.2 </entity> <entity type> monetaryItemType </entity type> <context> The company has a commercial paper program and the maximum aggregate balance of commercial paper outstanding may not exceed the borrowing capacity of $ 1.2 billion. Amounts outstanding under the commercial paper program are backstopped... | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
The company has a commercial paper program and the maximum aggregate balance of commercial paper outstanding may not exceed the borrowing capacity of $ 1.2 billion. Amounts outstanding under the commercial paper program are backstopped by available commitments under the company’s revolving credit facility. There were $... | text | 1.1 | monetaryItemType | text: <entity> 1.1 </entity> <entity type> monetaryItemType </entity type> <context> The company has a commercial paper program and the maximum aggregate balance of commercial paper outstanding may not exceed the borrowing capacity of $ 1.2 billion. Amounts outstanding under the commercial paper program are backstopped... | us-gaap:CommercialPaper |
The company has a commercial paper program and the maximum aggregate balance of commercial paper outstanding may not exceed the borrowing capacity of $ 1.2 billion. Amounts outstanding under the commercial paper program are backstopped by available commitments under the company’s revolving credit facility. There were $... | text | 173.4 | monetaryItemType | text: <entity> 173.4 </entity> <entity type> monetaryItemType </entity type> <context> The company has a commercial paper program and the maximum aggregate balance of commercial paper outstanding may not exceed the borrowing capacity of $ 1.2 billion. Amounts outstanding under the commercial paper program are backstopp... | us-gaap:CommercialPaper |
The company has a commercial paper program and the maximum aggregate balance of commercial paper outstanding may not exceed the borrowing capacity of $ 1.2 billion. Amounts outstanding under the commercial paper program are backstopped by available commitments under the company’s revolving credit facility. There were $... | text | 5.90 | percentItemType | text: <entity> 5.90 </entity> <entity type> percentItemType </entity type> <context> The company has a commercial paper program and the maximum aggregate balance of commercial paper outstanding may not exceed the borrowing capacity of $ 1.2 billion. Amounts outstanding under the commercial paper program are backstopped... | us-gaap:ShortTermDebtWeightedAverageInterestRate |
The company has a commercial paper program and the maximum aggregate balance of commercial paper outstanding may not exceed the borrowing capacity of $ 1.2 billion. Amounts outstanding under the commercial paper program are backstopped by available commitments under the company’s revolving credit facility. There were $... | text | 5.15 | percentItemType | text: <entity> 5.15 </entity> <entity type> percentItemType </entity type> <context> The company has a commercial paper program and the maximum aggregate balance of commercial paper outstanding may not exceed the borrowing capacity of $ 1.2 billion. Amounts outstanding under the commercial paper program are backstopped... | us-gaap:ShortTermDebtWeightedAverageInterestRate |
(a) Upon issuance of the 6.125 % notes due March 2026, the company entered into an interest rate swap, which effectively converts the 6.125 % notes to floating rate notes based on the secured overnight financing rate (“SOFR”) + 0.508 %, or an effective interest rate of 5.87 % at December 31, 2023. | text | 6.125 | percentItemType | text: <entity> 6.125 </entity> <entity type> percentItemType </entity type> <context> (a) Upon issuance of the 6.125 % notes due March 2026, the company entered into an interest rate swap, which effectively converts the 6.125 % notes to floating rate notes based on the secured overnight financing rate (“SOFR”) + 0.5... | us-gaap:DebtInstrumentInterestRateStatedPercentage |
(a) Upon issuance of the 6.125 % notes due March 2026, the company entered into an interest rate swap, which effectively converts the 6.125 % notes to floating rate notes based on the secured overnight financing rate (“SOFR”) + 0.508 %, or an effective interest rate of 5.87 % at December 31, 2023. | text | 0.508 | percentItemType | text: <entity> 0.508 </entity> <entity type> percentItemType </entity type> <context> (a) Upon issuance of the 6.125 % notes due March 2026, the company entered into an interest rate swap, which effectively converts the 6.125 % notes to floating rate notes based on the secured overnight financing rate (“SOFR”) + 0.5... | us-gaap:DerivativeVariableInterestRate |
(a) Upon issuance of the 6.125 % notes due March 2026, the company entered into an interest rate swap, which effectively converts the 6.125 % notes to floating rate notes based on the secured overnight financing rate (“SOFR”) + 0.508 %, or an effective interest rate of 5.87 % at December 31, 2023. | text | 5.87 | percentItemType | text: <entity> 5.87 </entity> <entity type> percentItemType </entity type> <context> (a) Upon issuance of the 6.125 % notes due March 2026, the company entered into an interest rate swap, which effectively converts the 6.125 % notes to floating rate notes based on the secured overnight financing rate (“SOFR”) + 0.50... | us-gaap:DebtInstrumentInterestRateEffectivePercentage |
The 7.50 % senior debentures are not redeemable prior to their maturity. All other notes may be called at the option of the company subject to “make whole” clauses. | text | 7.50 | percentItemType | text: <entity> 7.50 </entity> <entity type> percentItemType </entity type> <context> The 7.50 % senior debentures are not redeemable prior to their maturity. All other notes may be called at the option of the company subject to “make whole” clauses. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
The carrying amount of the company’s other short-term borrowings, 3.25 % notes due in 2024, North American asset securitization program, commercial paper, uncommitted lines of credit, and other obligations approximate their fair value. | text | 3.25 | percentItemType | text: <entity> 3.25 </entity> <entity type> percentItemType </entity type> <context> The carrying amount of the company’s other short-term borrowings, 3.25 % notes due in 2024, North American asset securitization program, commercial paper, uncommitted lines of credit, and other obligations approximate their fair value.... | us-gaap:DebtInstrumentInterestRateStatedPercentage |
The company has a $ 2.0 billion revolving credit facility maturing in September 2026. The facility may be used by the company for general corporate purposes including working capital in the ordinary course of business, letters of credit, repayment, prepayment or purchase of long-term indebtedness, acquisitions, and as ... | text | 2.0 | monetaryItemType | text: <entity> 2.0 </entity> <entity type> monetaryItemType </entity type> <context> The company has a $ 2.0 billion revolving credit facility maturing in September 2026. The facility may be used by the company for general corporate purposes including working capital in the ordinary course of business, letters of credi... | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
The company has a $ 2.0 billion revolving credit facility maturing in September 2026. The facility may be used by the company for general corporate purposes including working capital in the ordinary course of business, letters of credit, repayment, prepayment or purchase of long-term indebtedness, acquisitions, and as ... | text | 1.08 | percentItemType | text: <entity> 1.08 </entity> <entity type> percentItemType </entity type> <context> The company has a $ 2.0 billion revolving credit facility maturing in September 2026. The facility may be used by the company for general corporate purposes including working capital in the ordinary course of business, letters of credi... | us-gaap:DerivativeBasisSpreadOnVariableRate |
The company has a $ 2.0 billion revolving credit facility maturing in September 2026. The facility may be used by the company for general corporate purposes including working capital in the ordinary course of business, letters of credit, repayment, prepayment or purchase of long-term indebtedness, acquisitions, and as ... | text | 0.10 | percentItemType | text: <entity> 0.10 </entity> <entity type> percentItemType </entity type> <context> The company has a $ 2.0 billion revolving credit facility maturing in September 2026. The facility may be used by the company for general corporate purposes including working capital in the ordinary course of business, letters of credi... | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.